2019 Pediatric Spotlight - 8

LABORATORY


2ö1$*31#1-,@&22#120#7-331',%=

'+.*'$75-0)$*-5A0#13*21,".2'#,2+,%#+#,2@
&#
Q'4#"#0'2-0]*31712#+$-0.'"#2#!2'-,
-$
*3å1'+.*'$'#15-0)$*-5,".0-4'"#1!*#0,"/3'!)0#13*21
$-0..0-.0'2#.2'#,2+,%#+#,25'2&',2+#4'1'2@
F,# 322-,$3,!2'-,*'27A#172-31#,"'+.*#+#,2

#/3#12"#+-2-"72
%-@ "@!-+G#0'2-0#.

F,+ '%3-31"'%'2*$*30#13*2',3,"#0ÒÒ+',32#1?
F#+-,1202#".#0$-0+,!#!-+.0#"2-+-*#!3*02#121Ò
F-5!-12-$-5,#01&'.

'+.*72�'%&22#12$-0',$*3#,8A0-3.20#.,"@V
?#13*21$2#0ÒÑQ+',32#',!3 2'-,.#0'-"$-0
*3å,"C$2#0ÖQ+',32#',!3 2'-,.#0'-"$-00-3.20#.
V
Q#1.'02-077,!72'*'031
#$#0#,!#1BÒ@#0'2-0712#+$-0.'"#2#!2'-,-$
*3åA
Q5'4#")'2.!)%#',1#02AÙÑÙØ××ØHÒÕJÓÑÒÙQÑ×@
#0'2-0712#+$-0.'"#2#!2'-,-$
*3åA* -02-07)'2.!)%#',1#02AÙÑÙØ×××HÒÒJÓÑÒØQÒÑ@

AØ-4#2-,'0!*#A.0)1AÓÒÒÖÓQÑÚÚÚ#*BÒ@ÙÑÑ@×ÔÙ@Ù××Ô

[ÓÑÒÚ@A2&#-%-,"**-2"#+0)10#.0-.#027-$#!2-,A'!)',1-,,"-+.,7@

BD Veritor™ Plus System

The new wireless BD Veritor™ Plus System
provides health-care providers and laboratorians
in physician offices, clinics, hospitals, and
integrated delivery networks (IDNs) with
objective, lab-quality immunoassay test results
within minutes. This fast and accurate solution
streamlines the point-of-care (POC) diagnostic
workflow and allows providers to quickly review
patient results and determine the appropriate
treatment in a single consultation. The new
system can help detect infectious diseases such
as influenza A and B, respiratory syncytial virus
(RSV), and group A strep while the patient is still
on site, which can enable faster decision-making
for an earlier intervention opportunity.

BD Veritor™ System
Flu A+B Test Kit
The first CLIA-waived flu
A+B test referenced against
PCR, a higher sensitivity
standard than culture. Device is ready to insert
into reader 10 minutes after same is added.
* Positive percent agreement (A/B): 82.1%/74.6
* Negative percent agreement (A/B): 98.6%/99.6%
* Positive agreement vs. PCR for current visual
read rapid tests ranges from 10% to 70%
* Streamlined workflow: Provides a digital result in
<11 minutes, with <50 seconds of hands-on time
#256045
(992-0002)....................................................30/box
CPT® Codes: Influenza A: 87804QW† / Influenza B: 87804-59†; Using
the Objective and Differentiated Reader System: 87999†

8

* Faster access to test
results: Help inform
appropriate and targeted
treatment decisions
* Improved workflow:
The BD Veritor™ Plus
Analyzer improves
workflow with an Analyze Now or Walk Away
mode, providing test results (with a print-enabled
function) and aiding in decision-making while the
patient is on site
* Improved traceability: The BD Veritor™ InfoScan
module can scan 3 different identifiers (operator
ID, specimen ID, and test kit/lot) that can be
locally recorded, printed, or downloaded, and
reduces hands-on time through automated
documentation

BD Veritor™
System RSV
CLIA-Waived Kit
The first CLIA-waived RSV test referenced
against a higher sensitivity standard than culture.
Test device is ready to insert into reader 10
minutes after sample is added. The same sample
processed for RSV can also be used for flu A+B.
Digital results displayed in 10 seconds.
* Sample type: NP swab sample
* Positive percent agreement (PPA): 81.6%
* Negative percent agreement: (NPA): 99.1%
#256038
(121-7553).................................................... 30/box
CPT® Code: 87807QW†

To Order: 1.800.P.SCHEIN (1.800.772.4346) 8am-8:30pm, et

*

* Modularity: Provides a unique solution to meet
each testing site's preference
* Connectivity: BD Veritor™ InfoSync module
provides the same benefits as BD Veritor™
InfoScan. Connects and documents tests results
across multiple sites and can integrate with a
hospital electronic medical record or laboratory
information system
* Advanced particle technology: Enhances
sensitivity by using a proprietary process to
produce highly stable, modified colloidal metal
particles.
* Adaptive read technology: Compensates for
background. Nonspecific binding helps improve
specificity to reduce false-positive results
#256066
(126-5527)........................................................... ea

BD Veritor™
System Group A
Strep Test

The first CLIA-waived digital
immunoassay (DIA) for the rapid detection of
Group A strep (GAS) with an instrumented
result. Test device is ready to insert into reader
5 minutes after sample is added. Once the test
device is inserted in the reader, an objective,
digital test result is displayed in 10 seconds.
* Sample type: Throat swab sample
* Sensitivity*: 95.4%
* Specificity*: 95.7%
#256040
(992-0006)....................................................30/box

CPT® Code: 87880QW†
*Reference method: Bacterial culture; data from package insert.

To Fax: 1.800.329.9109 24 Hrs

19MS4178

http://go.bd.com/veritorep http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D1265527%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3DPediatricspotlight-2019%26utm_term%3D1265527 http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D9920002%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3DPediatricspotlight-2019%26utm_term%3D9920002 http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D9920006%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3DPediatricspotlight-2019%26utm_term%3D9920006 http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D1217553%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3DPediatricspotlight-2019%26utm_term%3D1217553

2019 Pediatric Spotlight

Table of Contents for the Digital Edition of 2019 Pediatric Spotlight